PL358032A1 - Nowe zastosowanie 22R-(11, 16 )-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna-1,4-dieno-3,20-dionu - Google Patents

Nowe zastosowanie 22R-(11, 16 )-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna-1,4-dieno-3,20-dionu

Info

Publication number
PL358032A1
PL358032A1 PL02358032A PL35803202A PL358032A1 PL 358032 A1 PL358032 A1 PL 358032A1 PL 02358032 A PL02358032 A PL 02358032A PL 35803202 A PL35803202 A PL 35803202A PL 358032 A1 PL358032 A1 PL 358032A1
Authority
PL
Poland
Prior art keywords
dihydroxypregna
butylidene
dione
diene
oxy
Prior art date
Application number
PL02358032A
Other languages
English (en)
Other versions
PL207060B1 (pl
Inventor
Beata Rostkowska-Nadolska
Stanisław Szymaniec
Wojciech Fortuna
Wiesław Szelejewski
Teresa Uszycka-Horawa
Hanna Zakrzewska-Karniewicz
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Priority to PL358032A priority Critical patent/PL207060B1/pl
Publication of PL358032A1 publication Critical patent/PL358032A1/pl
Publication of PL207060B1 publication Critical patent/PL207060B1/pl

Links

PL358032A 2002-12-30 2002-12-30 Zastosowanie 22R-(11 β,16α)-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna- -1,4-dieno-3,20-dionu i środek farmaceutyczny PL207060B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL358032A PL207060B1 (pl) 2002-12-30 2002-12-30 Zastosowanie 22R-(11 β,16α)-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna- -1,4-dieno-3,20-dionu i środek farmaceutyczny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL358032A PL207060B1 (pl) 2002-12-30 2002-12-30 Zastosowanie 22R-(11 β,16α)-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna- -1,4-dieno-3,20-dionu i środek farmaceutyczny

Publications (2)

Publication Number Publication Date
PL358032A1 true PL358032A1 (pl) 2004-07-12
PL207060B1 PL207060B1 (pl) 2010-10-29

Family

ID=32845081

Family Applications (1)

Application Number Title Priority Date Filing Date
PL358032A PL207060B1 (pl) 2002-12-30 2002-12-30 Zastosowanie 22R-(11 β,16α)-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna- -1,4-dieno-3,20-dionu i środek farmaceutyczny

Country Status (1)

Country Link
PL (1) PL207060B1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3182467T1 (sl) 2015-12-15 2020-04-30 Ml System Spolka Akcyjna Žaluzijska letev za fotovoltaični modul in postopek za povezave le-te z modulom

Also Published As

Publication number Publication date
PL207060B1 (pl) 2010-10-29

Similar Documents

Publication Publication Date Title
AU2003245660A1 (en) Task based polymorphic graphical program function nodes
AU2002356759A1 (en) 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
IS7425A (is) Flúraðar 4-azasteróíð afleiður sem andrógen viðtakastillar
AU2003202044A1 (en) 17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
AU2002353158A1 (en) Installation of evacuated tubular conduits
AU2002361758A1 (en) Based, triple-well fully depleted soi structure, and various methods of making and operating same
AU2003304425A1 (en) Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
AU2003233733A1 (en) Compositions for cancer therapy saponins or sapogenins
WO2003082894A3 (en) C-17 spirolactonization and 6,7 oxidation of steroids
NO20031964D0 (no) Fremgangsmåte for fremstilling av 16,17- [(cykloheksylmetylen)bis(oksy)]-11,21-dihydroksy-pregna-1,4-dien-3,20-dion eller dets 21-isobutyratved transketalisering
AU2003270680A1 (en) Tubular structures and methods for making the same
AU2003237767A1 (en) Single wafer fabrication of integrated micro-fluidic system
PL358032A1 (pl) Nowe zastosowanie 22R-(11, 16 )-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna-1,4-dieno-3,20-dionu
HU9201190D0 (en) Method for producing new pregna-1,4-diene-3,20-dione derivatives
AU2003289207A1 (en) Anti-inflammatory agent
ATE433457T1 (de) Angiogen-wirkende trisulfat steroide und deren verwendung
PL361730A1 (pl) Podstawione w pozycji 7 i chlorowcowane w pozycji11 steroidy o działaniu androgenowym
NO20043455L (no) Fremgangsmate for fremstilling av 7alfa-metylsteroider
IS7452A (is) Prógesterón viðtakastillar sem ekki eru steratengdir
AU2003251362A1 (en) Compositions formed from the reduction of lanolin
WO2003032924A3 (en) Novel tibolone formulations
AU2003224716A1 (en) Method of tensile flow forming
IL164233A0 (en) A process for the preparation of 6-alfa-fluoro steroids
AU2002306108A1 (en) A method for preparation of androst-4-ene-3,17-dione and androsta-1,4-diene-3,17-dione
MXPA03011751A (es) Proceso para preparar 21-acetato de 11b,17a, 21-trihidroxi-6a-metilpregna-1, 4-dieno-3, 20- diona.

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20131230